<DOC>
	<DOCNO>NCT00165438</DOCNO>
	<brief_summary>The purpose study find impact Bleomycin-containing chemotherapy , give without chest radiation therapy , patient ' lung function time .</brief_summary>
	<brief_title>Pulmonary Function Patients With Hodgkin 's Disease Receiving Bleomycin-Based Chemotherapy</brief_title>
	<detailed_description>- The test procedure study part regular cancer care study offer structure time standard test . - Due potential lung toxicity associate bleomycin-based chemotherapy , pulmonary function test routinely perform . Pulmonary function test perform licensed , register respiratory therapist perform prior beginning treatment , chemotherapy radiation therapy ( patient receive chemotherapy radiation therapy ) , approximately 1 month , 6 month , 1 year 2 year completion treatment . - A CAT scan perform prior beginning treatment , approximately 1 month , 6 month , 1 year 2 year completion treatment . - A self-administered questionnaire perform day patient undergoing pulmonary function test .</detailed_description>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>Patients newly diagnose classical Hodgkin 's disease , mediastinal involvement Bleomycinbased chemotherapy alone combination mediastinal irradiation Prior chest irradiation Mediastinal irradiation receive outside institution Refractory progressive disease treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Pulmonary function</keyword>
	<keyword>Bleomycin-based chemotherapy</keyword>
	<keyword>mediastinal irradiation</keyword>
</DOC>